Tag: Proteasome inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Proteasome inhibitor

FDA ODAC Committee Votes in Favor of Benefit-Risk Profile of Ide-Cel in Early R/R Myeloma

Added to Collection on: 2024-03-15 21:27:46

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Ide-Cel Earns European Approval in Triple-Class Exposed Multiple Myeloma

Added to Collection on: 2024-03-21 21:01:54

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
FDA Approves CARVYKTI® and ABECMA for Early Treatment of Adult Patients with ...

Added to Collection on: 2024-04-08 20:46:43

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Key Trials From ASH 2024 Impact Treatment for Plasma Cell Disorders Going Forward

Added to Collection on: 2025-02-20 14:05:40

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance

Added to Collection on: 2025-03-20 21:39:56

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Elotuzumab Plus PVd May Be Effective in Relapsed, Refractory MM - Hematology Advisor

Added to Collection on: 2025-04-25 13:32:36

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Treatment Line Trends In The European Multiple Myeloma Therapeutics Market

Added to Collection on: 2025-05-13 10:37:09

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Elotuzumab Plus PVd May Be Effective in Relapsed, Refractory MM

Added to Collection on: 2025-07-11 13:09:29

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
What Does Multiple Myeloma Mean? - Cure Today

Added to Collection on: 2025-08-22 19:30:41

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety

Added to Collection on: 2025-09-18 23:02:21

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Book a Demo